Earlier this week, Baird Capital portfolio company Upfront, the patient engagement and access platform, announced an additional $10.5 million in funding to accelerate its growth and product development initiatives.
Baird Capital’s Venture team led the funding round alongside Echo Health Ventures and First Trust Capital Partners, with additional participation from existing investors including LRVHealth, Hyde Park Venture Partners, and Nashville Capital Network.
"We are very excited to increase our investment in Upfront and partner with the company's leadership team as they continue to drive innovation and enhanced patient experience for their client partners," said Jim Pavlik, Baird Capital Venture Partner. "Given Upfront's deep healthcare expertise, strong product differentiation, and proven approach, we believe the company is extremely well-positioned to capture increased market share and expand its positive impact on patient access and care delivery over the coming years."
The Series C news comes on the heels of Upfront's strategic acquisition of PatientBond, a leader in consumer science for healthcare, creating a single enterprise technology solution to drive patient acquisition and loyalty.